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The vasodilatory effect of diltiazem and nitroglycerin on the large epicardial coronary arteries was
evaluated in 26 patients with coronary artery disease. The luminal area of a normal and a stenotic
coronary artery was determined at rest, after intracoronary administration of diltiazem, during
submaximal exercise as well as 5min after l-6mg sublingual nitroglycerin using biplane quantitative
coronary arteriography. Twelve patients with no pretreatment prior to the exercise test served as group
1 (controls) and 14 patients with intracoronary administration of 2 to 3mg diltiazem prior to the
exercise test as group 2.
Normal vessel: In the control group luminal area increased significantly during exercise (+23%,
P < 0-01) and after sublingual administration of nitroglycerin (+40%, P < 0001). In group 2 luminal
area increased after intracoronary administration of diltiazem (+19%, P<0-01), during bicycle
exercise (+23%, P<0-001) and after sublingual administration of nitroglycerin (+39%, P <0001).
Stenotic vessel: In the control group luminal area decreased significantly (—29%, P < 0-001) during
bicycle exercise but increased after sublingual administration of nitroglycerin at the end of the exercise
test (+12%, NS vs. rest). In group 2 intracoronary administration of diltiazem was associated with a
mild increase in stenosis area (+11%, P <0-05). There was a further increase in stenosis area during
bicycle exercise (+23%, P <0001 vs. rest) and after sublingual nitroglycerin (+32%, P<0001).
Coronary vasodilation of the stenotic segment was, however, significantly more pronounced after
sublingual nitroglycerin in group 2 than 1 (+32% versus 12%, P <0-05).
Thus, it is concluded that diltiazem prevents exercise-induced coronary vasoconstriction of the
stenotic vessel segment probably due to its direct vasorelaxing action on the smooth vasculature.
Diltiazem combined with nitroglycerin elicits an additive effect on coronary vasodilation of the
stenotic vessel segments but not on the normal coronary arteries. The exact mechanism of this additive
effect is not clear but might be due to the combined action of the two vasoactive drugs with different
mode of action.
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during dynamic exercise in patients with
coronary artery disease.
Patients and methods
Twenty-six patients with a mean age of 55
years (range from 36 to 67 years) were included
in the present study. A history of angina pectoris
and/or ST-segment depression ?0- lmV in the
upright bicycle exercise test was present in all
patients. The patients were recruited on a
consecutive basis when a history of stable angina
pectoris with no signs of coronary vasospasm
and a clearly visible coronary artery stenosis for
quantitative evaluation was present. The first 12
patients constituted the control group and the
following 14 patients the diltiazem group. There
were no significant differences between the two
groups in regard to clinical findings or baseline
haemodynamics. All medication was stopped at
least 12 to 24 h before cardiac catheterization.
STUDY PROTOCOL
After the diagnostic coronary arteriography
(Judkins technique) an interval of at least 10 min
was allowed for dissipation of the effects of the
contrast medium on coronary vasomotion. After
the patient's feet were attached to the bicycle
ergometer biplane, coronary arteriography was
performed'3'41. Aortic and pulmonary artery
pressure were recorded immediately before
coronary arteriography. Biplane coronary ar-
teriography was repeated at the end of each
level of exercise which was begun at 50 to 75 W
and was increased every 2 min in increments of
25 to 50 W. The exercise was terminated
because of anginal pain, fatigue or ST-segment
depression of more than 0-2 mV. Two to 3 mg
diltiazem were infused prior to the exercise test
in group 2 (= diltiazem group) into the coronary
artery which was selected for quantitative
analysis. At the end of the exercise test 1-6 mg
sublingual nitroglycerin was administered in
both groups and biplane coronary arteriography
was repeated 5 min thereafter. There were no
complications related to the procedure in any of
the 26 patients.
QUANTITATIVE CORONARY ARTERIOGRAPHY
The currently used technique for quantitation
of coronary artery stenoses has been described
elsewhere'34'. The evaluation was performed in
a blinded fashion. A normal and a stenotic
vessel segment were traced manually 4 to 6
times and the results were averaged to reduce
sampling error. The tracings were digitized and
analysed on a PDP 11/34 computer. Interobser-
ver variability was 9-3% of the mean vessel area
for monoplane and 7-9% for biplane
measurements'3'4'.
STATISTICS
Comparisons of pressure and angiographic
data in response to diltiazem, bicycle exercise
and sublingual nitroglycerin was performed by a
two-way analysis of variance for repeated
measurements. Comparisons between group 1
and 2 were carried out by an unpaired Student
Mest.
Results
PRESSURE MEASUREMENTS
Mean aortic and mean pulmonary artery
pressure (Fig. 1) increased significantly during
bicycle exercise from 87 mmHg to 107 mmHg
( P < 0-001) and from 26 to 47 mmHg, respec-
tively in the control group. In group 2 mean
aortic pressure decreased significantly from
100mmHg to 89mmHg (/><001) after in-
tracoronary administration of diltiazem and
increased slightly to 101 mmHg (NS vs. rest)
during exercise. Mean pulmonary artery pres-
sure remained unchanged after intracoronary
administration of diltiazem but increased sig-
nificantly from 22 mmHg to 37 mmHg (P <
0001) during bicycle exercise. Sublingual
administration of 1-6 mg nitroglycerin was
associated with a fall in mean aortic pressure in
both groups but the decrease in mean aortic
pressure was statistically significant (P<0001
vs. rest) only in group 2. Mean pulmonary artery
pressure dropped in both groups after sublingual
nitroglycerin but significantly (P < 0-01) more in
group 2 (15 mmHg) than 1 (24 mmHg).
ANGIOGRAPHIC MEASUREMENTS
The individual changes in coronary luminal
area of the stenotic vessel segment are shown in
Fig. 2 and the mean changes ±1 standard error
for both normal and stenotic vessel segments are
depicted in Fig. 3. The individual stenoses
(Fig. 2) showed a tendency to increase its area
after intracoronary administration of diltiazem
and during subsequent bicycle exercise. There
was a further increase in most patients (8 out of
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Figure 1 Mean aortic pressure (MAP) and mean
pulmonary artery pressure (MPAP) in 26 patients with
coronary artery disease and exercise-induced angina
pectoris. Twelve patients with no pretreatment prior to
exercise test served as control group (dots with solid
lines) and 14 patients with intracoronary administration
of 2-3 mg diltiazem prior to exercise as group 2 (circles
with dashed lines). Both mean aortic and mean
pulmonary artery pressure rose significantly during
exercise (ex) in the control group but aortic pressure
dropped after intracoronary administration of diltiazem
and did not rise compared to rest during exercise in group
2. Mean pulmonary artery pressure rose significantly in
group 2 during exercise but was significantly lower than in
group 1. 2 min. ex, 2 min. of exercise; max. ex, maximal
exercise; NTG s.l., sublingual nitroglycerin.
14) after sublingual administration of nitro-
glycerin.
Normal coronary vessel segments (Fig. 3)
showed coronary vasodilation during exercise
(+23%, />< 0-001) and after sublingual ad-
ministration of nitroglycerin (+40%, P < 0-001)
in the control group. In group 2 there was
coronary vasodilation (+19%, P<001) after
intracoronary administration of diltiazem and
during bicycle exercise (+23%, P < 0-001).
Sublingual nitroglycerin further dilated the
normal vessel segments to a similar extent as in
the control group (+39%, P <0-001).
Diltiazem i.e.
NTG
Exercise
Figure 2 Changes' in stenosis area for all 14 patients with
intracoronary administration of 2-3 mg diltiazem (group
2) prior to the exercise test. Given are the data at rest
(C), after intracoronary (i.e.) administration of diltiazem,
at each minute of the exercise test as well as 5 min after
1.6 mg sublingual nitroglycerin. The occurrence of angina
pectoris during exercise is indicated by an asterisk. There
is a tendency to increase coronary stenosis area after
intracoronary diltiazem, during bicycle exercise and after
sublingual nitroglycerin.
Stenotic coronary vessel segments (Fig. 3)
showed a completely different behaviour in
groups 1 and 2. In the control group there was
exercise-induced coronary vasoconstriction
(-29%, P < 0-001), whereas in group 2 intra-
coronary administration of diltiazem was associ-
ated with a mild increase (+11%, P<005)
and bicycle exercise with a significant increase in
stenosis area (+23%, P< 0001 vs. rest).
Sublingual administration of nitroglycerin led in
both groups to coronary vasodilation (group 1:
+ 12%, NS vs. rest; group 2: +32%, P<0001
vs. rest) which was, however, significantly more
pronounced in group 2 than 1 (P < 005).
Discussion
Diltiazem represents a potent coronary vasodi-
lator which reduces the influx of calcium via the
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Figure 3 Changes in mean coronary luminal area of the normal (left) and stenotic
(right) vessel segment. The data are given in percent of the control value. Twelve
patients with no pretreatment prior to the exercise test served as controls (group 1;
dots with solid lines) and 14 patients with intracoronary administration of 2-3 mg
diltiazem as group 2 (circles with dashed lines). The normal vessels showed coronary
vasodilation during exercise in both groups, whereas the stenotic vessel demonstrated
coronary vasoconstriction during exercise in the control group which was, however,
prevented by intracoronary diltiazem in group 2. Sublingual nitroglycerin elicited an
additive effect on vasodilation of the stenotic (+39% vs. +12%, P<0-05) but not of
the normal vessel (+39% vs. +40%, NS). Abbreviations see Fig. 1.
slow-calcium channels into the vascular smooth
musculature. Nitroglycerin is also a potent
coronary vasodilator which stimulates the
guanylate cyclase with a consecutive rise in
cyclic guanosine monophosphate in the smooth
musculature which induces coronary vasodila-
tion. Both drugs are well established in the
treatment of patients with coronary artery
disease and both have been shown to be highly
efficient in the reduction of myocardial
ischemia156'. Calcium antagonists and nitrates
are often combined in the daily routine for an
optimal anti-ischaemic effect in patients with
angina pectoris although clinical trials did not
show a better result for the combined regimen
than for either drug alone'6'. Thus, the purpose
of the present study was to evaluate the effect of
diltiazem alone and combined with sublingual
nitroglycerin on coronary vasomotion of normal
and stenotic coronary arteries at rest and during
dynamic exercise in patients with exercise-
induced ischaemia.
The effect of intracoronary administration of
diltiazem on coronary vasomotion was similar
for the normal and the stenotic vessel segment
although the increase in luminal area was
somewhat larger for the normal (+19%,
P<00l) than for the stenotic vessel segment
(+11%, NS). Exercise-induced coronary vaso-
constriction was, however, prevented by in-
tracoronary administration of diltiazem. The
exact mechanism of exercise-induced stenosis
vasoconstriction and its prevention by intracoro-
nary diltiazem is not clear but might be due to
the following 3 factors:
(1) Insufficient production (atherosclerotic
plaques) of the endothelium-derived relaxing
factor during exercise; (2) platelet aggregation
with release of thromboxane A2 and serotonin
due to turbulent blood flow; and (3) passive
collapse of the free vessel wall within the
stenosis due to high blood flow velocities during
exercise (Venturi mechanism). Diltiazem could
potentially restore endothelial function with a
higher production of the endothelium-derived
relaxing factor during exercise or could reduce
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turbulent blood flow and therefore platelet
aggregation by coronary vasodilation and could
prevent the passive collapse of the free vessel
wall by a reduction in blood flow velocity
(coronary vasodilation) during exercise. Which
of these 3 factors is responsible for the
exercise-induced vasoconstriction and which of
the postulated effects of diltiazem prevents the
exercise-induced vasoconstriction cannot be
derived from the present study.
Sublingual administration of nitroglycerin at
the end of the exercise test was associated with a
significant increase in coronary luminal area of
the normal vessel segments in both groups
(+40% in group 1 vs. +39% in group 2, NS).
The stenotic vessel segments showed, however,
only a mild increase (+12%, NS vs. rest) in
stenosis area after sublingual nitroglycerin in the
control group, whereas stenosis area significantly
increased (+32%, P < 0-001 vs. rest) in patients
pretreated with diltiazem (group 2). Apparently,
the combination of both drugs seems to have an
additive effect on coronary vasodilation of the
stenotic but not of the normal vessel segment.
The exact mechanism of this additive effect is
not clear but might be related to the different
mode of action of the two drugs as mentioned
earlier: diltiazem reduces the calcium influx into
the smooth muscle cell, whereas nitroglycerin
increases the cyclic guanosine monophosphate in
the vascular musculature. This combined action
on the vascular smooth musculature of the
diseased coronary artery appears to be respon-
sible for maximal dilation of the stenotic vessel
segments which exceeds that achieved by
diltiazem or nitroglycerin131 alone.
References
[1] Brown BG, Bolson EL, Dodge HT. Dynamic
mechanisms in human coronary stenosis. Circulation
1984; 70: 917-22.
[2] Brown BG, Lee AB, Bolson EL, Dodge HT. Reflex
constriction of significant coronary stenosis as a
mechanism contributing to ischemic left ventricular
dysfunction during isometric exercise. Circulation
1984; 70: 18-24.
[3] Gage JE, Hess OM, Murakami T, Ritter M, Grimm
J, Krayenbuehl HP. Vasoconstriction of stenotic
coronary arteries during dynamic exercise in patients
with classic angina pectoris: reversibility by nitro-
glycerin. Circulation 1986; 73: 865-76.
[4] Gaglione A, Hess OM, Conn WJ, Ritter M, Grimm
J, Krayenbuehl HP. Is there coronary vasoconstric-
tion after intracoronary beta-adrenergic blockade in
patients with coronary artery disease? J Am Coll
Cardiol 1987; 10: 299-310.
[5] Boden WE, Bough EW, Reichmann MJ, Rich VB,
Young PM, Korr KS, Shulman RS. Beneficial effects
of high-dose diltiazem in patients with persistent
effort angina on beta-blockers and nitrates: a
randomized, double-blind placebo-controlled cross-
over study. Circulation 1985; 71: 1197-205.
[6] Hossack KF, Eldridge JE, Buckner K. Comparison of
acute hemodynamic effects of nitroglycerin versus
diltiazem and combined acute effects of both drugs in
angina pectoris. Am J Cardiol 1986; 58: 722-6.
